A detailed history of Fcf Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Fcf Advisors LLC holds 12,688 shares of AMGN stock, worth $3.35 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
12,688
Holding current value
$3.35 Million
% of portfolio
0.97%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $3.93 Million - $4.28 Million
12,688 New
12,688 $4.09 Million
Q4 2023

Jan 04, 2024

BUY
$255.7 - $288.46 $1.01 Million - $1.14 Million
3,969 Added 85.8%
8,595 $2.48 Million
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $756,091 - $938,708
3,458 Added 296.06%
4,626 $1.24 Million
Q2 2023

Jul 19, 2023

SELL
$214.27 - $253.37 $1.92 Million - $2.28 Million
-8,979 Reduced 88.49%
1,168 $259,000
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $771,524 - $940,358
3,417 Added 50.77%
10,147 $2.45 Million
Q4 2022

Feb 03, 2023

SELL
$229.03 - $291.01 $34,354 - $43,651
-150 Reduced 2.18%
6,730 $1.77 Million
Q3 2022

Oct 12, 2022

SELL
$224.46 - $253.15 $538,479 - $607,306
-2,399 Reduced 25.85%
6,880 $1.55 Million
Q2 2022

Jul 20, 2022

SELL
$230.71 - $256.74 $2.1 Million - $2.34 Million
-9,101 Reduced 49.52%
9,279 $2.26 Million
Q1 2022

Apr 28, 2022

BUY
$219.27 - $242.57 $1.81 Million - $2.01 Million
8,271 Added 81.82%
18,380 $4.45 Million
Q2 2021

Jul 30, 2021

SELL
$233.58 - $259.14 $174,717 - $193,836
-748 Reduced 6.89%
10,109 $2.45 Million
Q1 2021

Apr 06, 2021

BUY
$221.91 - $258.6 $2.41 Million - $2.81 Million
10,857 New
10,857 $2.75 Million
Q1 2019

Apr 09, 2019

SELL
$180.87 - $203.88 $909,776 - $1.03 Million
-5,030 Closed
0 $0
Q4 2018

Jan 15, 2019

BUY
$178.4 - $208.25 $634,033 - $740,120
3,554 Added 240.79%
5,030 $979,000
Q3 2017

Dec 01, 2017

BUY
$167.29 - $191.0 $36,134 - $41,256
216 Added 17.14%
1,476 $275,000
Q2 2017

Aug 07, 2017

BUY
N/A
1,260
1,260 $217,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fcf Advisors LLC Portfolio

Follow Fcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fcf Advisors LLC with notifications on news.